PharmD Info

A forum for Indian Pharmacy Professionals

New Drug Information's and other safety information, drug label changes, and Dose and Dosage Calculations, CDCSO,PvPI and FDA Safety Alerts and etc.
  • User avatar
#2862
The first medicine designed to prevent migraines was approved by the Food and Drug Administration on Thursday, ushering in what many experts believe will be a new era in treatment for people who suffer the most severe form of these headaches.

The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. The list price will be $6,900 a year, and Amgen said the drug will be available to patients within a week.

References:

https://www.fda.gov/newsevents/newsroom ... 608120.htm
Similar Topics
Topics Statistics Last post
0 Replies 
781 Views
by Srikanthpm
0 Replies 
856 Views
by Swathi Swaroopa B
1 Replies 
1242 Views
by Mugilraj
2 Replies 
2531 Views
by amirsiddiqui
5 Replies 
2162 Views
by Reenaselvi.s

Check Here to get the updates on oncology Phar[…]

When will the new (2022) batch start for fellowshi[…]

Vacancy for the post of Assistant Professor in the[…]

Clinical pharmacist vacancy in Fortis Hospital, Mu[…]

PharmD Info - Highlights